Good presentation.
Mid study point is now going to be released in July, 2 weeks after anticipated primary release date.
Some good data coming through, they both, IMO, seem quite positive on the study and the use of ATH434.
Some of the new data looks like it may be added to the end points of the study, to assist with FDA approval.
Anyone else watch it ?.
If so, thoughts ?.
Ann: Webcast Today - New Data from bioMUSE Natural History Study, page-4
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $7.879K | 2.590M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 79758033 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 1157860 | 1 |
View Market Depth
| Last trade - 15.57pm 17/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |